Document is current
Any future updates will be listed below
-
Authors
Corral Nieto, Yaiza
Fernández Pereira, Amanda Gabrielly https://orcid.org/0009-0000-7254-964X
Ventura-San Pedro, Laura https://orcid.org/0009-0001-6976-7766
Paredes, Sonia Belén https://orcid.org/0009-0003-1991-446X
Pérez-Cobas, Ana Elena https://orcid.org/0000-0002-3995-5571
Perez-Lanzon, María
Durand, Sylvere
Moreno-Cruz, Paula https://orcid.org/0000-0002-2412-5460
Manrique, Laura
Benítez-Fernández, Rocío https://orcid.org/0000-0003-3535-4370
Leal Lassalle, Héctor https://orcid.org/0000-0002-5193-4140
Nevzorova, Yulia A. https://orcid.org/0000-0003-1390-8002
Cubero, Francisco Javier https://orcid.org/0000-0003-1499-650X
Alechaga, Élida https://orcid.org/0000-0002-6698-7544
Pozo, Oscar J. https://orcid.org/0000-0002-1735-9728
Boya, Patricia
Fuentes, José Manuel https://orcid.org/0000-0001-6910-2089
Sica, Valentina https://orcid.org/0000-0003-2770-5847
Kroemer, Guido https://orcid.org/0000-0002-9334-4405
Bravo-San Pedro, José Manuel https://orcid.org/0000-0002-5781-1133
- License Information
-
More Information
Article History
Received: 18 December 2023
Accepted: 4 November 2025
First Online: 9 January 2026
Competing interests
: J.M.B.-S.P. and G.K. are co-inventors on ACBP-relevant patents. G.K. has been holding research contracts with Daiichi Sankyo, Eleor, Kaleido, Lytix Pharma, PharmaMar, Osasuna Therapeutics, Samsara Therapeutics, Sanofi, Tollys, and Vascage. G.K. is on the Board of Directors of the Bristol Myers Squibb Foundation France. G.K. is a scientific cofounder of everImmune, Osasuna Therapeutics, Samsara Therapeutics, and Therafast Bio. G.K. is in the scientific advisory boards of Hevolution, Institut Servier, and Longevity Vision Funds. G.K. is the inventor of patents covering therapeutic targeting of aging, cancer, cystic fibrosis, and metabolic disorders. The remaining authors declare no competing interests.
